OK-432 upregulated the expression of CD56 and cell surface TRAIL and Fas ligand on mIFN-DCs, and the independent involvement of TRAIL and Fas ligand in mIFN-DC-mediated tumour killing was proven via specific antibody blockade. The gene discussed is NCAM1; the disease is neoplasm.